Loomis, Sayles & Company’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6M | Sell |
657,165
-15,846
| -2% | -$496K | 0.03% | 239 |
|
|
2025
Q1 | $22.6M | Sell |
673,011
-14,134
| -2% | -$474K | 0.03% | 225 |
|
|
2024
Q4 | $26.9M | Sell |
687,145
-20,077
| -3% | -$787K | 0.03% | 213 |
|
|
2024
Q3 | $27.8M | Buy |
707,222
+46,964
| +7% | +$1.85M | 0.04% | 211 |
|
|
2024
Q2 | $25.7M | Sell |
660,258
-26,252
| -4% | -$1.02M | 0.04% | 216 |
|
|
2024
Q1 | $29.6M | Sell |
686,510
-21,785
| -3% | -$938K | 0.04% | 202 |
|
|
2023
Q4 | $32.6M | Sell |
708,295
-22,421
| -3% | -$1.03M | 0.05% | 182 |
|
|
2023
Q3 | $25M | Sell |
730,716
-22,810
| -3% | -$779K | 0.04% | 214 |
|
|
2023
Q2 | $29M | Sell |
753,526
-7,041
| -0.9% | -$271K | 0.05% | 196 |
|
|
2023
Q1 | $27.2M | Buy |
760,567
+83,402
| +12% | +$2.98M | 0.05% | 194 |
|
|
2022
Q4 | $26.7M | Buy |
+677,165
| New | +$26.7M | 0.05% | 189 |
|